Weight Loss
Mental Health
Hair Regrowth
More
Login
Together, we've reported
306,352
GLP-1 shortages to the FDA
Shortage report
Feb 2 - 8
Updated: 9 days ago
Cumulative
37
%
MoM increase in GLP-1
shortage reports
09/01
09/08
09/15
09/22
09/29
10/06
10/13
10/20
10/27
11/03
11/10
11/17
11/24
12/01
12/08
12/15
12/22
12/29
01/05
01/12
01/19
01/26
306,352
02/02
Trending worse
MS
147%
more shortage reports this week
Trending worse
FL
1,348
more shortage reports this week
Medications
The majority of shortages are name brand
Semaglutide
and
Tirzepatide
Wegovy®
(Semaglutide)
Wegovy®
(Semaglutide)
85,645
Ozempic®
(Semaglutide)
Ozempic®
(Semaglutide)
84,802
Mounjaro®
(Tirzepatide)
Mounjaro®
(Tirzepatide)
44,818
Unspecified
Unspecified
43,586
Zepbound®
(Tirzepatide)
Zepbound®
(Tirzepatide)
38,257
Saxenda® or Victoza
(Liraglutide)
Saxenda® or Victoza
(Liraglutide)
4,753
Trulicity®
(Dulaglutide)
Trulicity®
(Dulaglutide)
4,491
Trending worse
Trulicity
®
7%
more shortage reports this week
Trending worse
Ozempic
®
5,006
more shortage reports this week
By state
Florida
22,590
+1,348
Texas
21,050
+1,163
New York
17,690
+900
California
23,654
+872
Pennsylvania
14,182
+817
Report a GLP-1 shortage